Dareen Siri

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

Brian P. Vickery, Andrea Vereda, Caroline Nilsson et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 90 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Jacqueline A. Pongracic, Rémi Gagnon, Gordon L. Sussman et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 62 citations · Full text

Life Sciences, Pediatrics, Pharmacotherapy +17

560 KPL-716, anti-Oncostatin M receptor beta antibody, reduced pruritus in atopic dermatitis

Zamaneh Mikhak, Robert Bissonnette, Dareen Siri et al. · Journal of Investigative Dermatology · 2019 · 21 citations

Medicine, Dermatology, Immunology +14

Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study

Lawrence F. Eichenfield, Linda Stein Gold, Eric L. Simpson et al. · Journal of the American Academy of Dermatology · 2025 · 14 citations · Full text

Medicine, Dermatology, Pediatrics +14